Publications

Found 5 results
Filters: Author is M.N. Klautau-Guimarães  [Clear All Filters]
2012
G. S. Lordelo, Miranda-Vilela, A. L., Akimoto, A. K., Alves, P. C. Z., Hiragi, C. O., Nonino, A., Daldegan, M. B., Klautau-Guimarães, M. N., and Grisolia, C. K., Association between methylene tetrahydrofolate reductase and glutathione S-transferase M1 gene polymorphisms and chronic myeloid leukemia in a Brazilian population, vol. 11, pp. 1013-1026, 2012.
Alves-Silva J, da Silva SM, Guimaraes PE, Ferreira AC, et al. (2000). The ancestry of Brazilian mtDNA lineages. Am. J. Hum. Genet. 67: 444-461. http://dx.doi.org/10.1086/303004 PMid:10873790 Anisimov VN (2007). Biology of aging and cancer. Cancer Control 14: 23-31. Barbosa CG, Souza CL, Moura Neto JP, Arruda MGB, et al. (2008). Methylenetetrahydrofolate reductase polymorphisms in myeloid leukemia patients from Northeastern Brazil. Genet. Mol. Biol. 31: 29-32. http://dx.doi.org/10.1590/S1415-47572008000100005 Barreiro LB, Laval G, Quach H, Patin E, et al. (2008). Natural selection has driven population differentiation in modern humans. Nat. Genet. 40: 340-345. http://dx.doi.org/10.1038/ng.78 PMid:18246066 Bowen DT, Frew ME, Rollinson S, Roddam PL, et al. (2003). CYP1A1*2B (Val) allele is overrepresented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication. Blood 101: 2770-2774. http://dx.doi.org/10.1182/blood-2002-01-0228 PMid:12468438 Campregher PV, Lorand-Metze I, Grotto HZW and Sonati MF (2004). Haptoglobin phenotypes in Brazilian patients with leukemia. Braz. J. Pathol. Lab. Med. 40: 307-309. http://dx.doi.org/10.1590/S1676-24442004000500005 Carter K and Worwood M (2007). Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases. Int. J. Lab. Hematol. 29: 92-110. http://dx.doi.org/10.1111/j.1751-553X.2007.00898.x PMid:17474882 Chen CL, Liu Q and Relling MV (1996). Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 6: 187-191. http://dx.doi.org/10.1097/00008571-199604000-00005 PMid:9156696 Chin YM, Bosco JJ and Koh CL (1992). Analysis of ras gene mutations in acute myeloid leukemia by the polymerase chain reaction and oligonucleotide probes. Singapore Med. J. 33: 48-50. PMid:1598607 Cotton SC, Sharp L, Little J and Brockton N (2000). Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am. J. Epidemiol. 151: 7-32. http://dx.doi.org/10.1093/oxfordjournals.aje.a010124 PMid:10625170 Crump C, Chen C, Appelbaum FR, Kopecky KJ, et al. (2000). Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia. Cancer Epidemiol. Biomarkers Prev. 9: 457-460. PMid:10815689 Duthie SJ, Narayanan S, Brand GM, Pirie L, et al. (2002). Impact of folate deficiency on DNA stability. J. Nutr. 132: 2444S-2449S. PMid:12163709 Franco RF, Morelli V, Lourenco D, Maffei FH, et al. (1999). A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease. Br. J. Haematol. 105: 556-559. http://dx.doi.org/10.1111/j.1365-2141.1999.01254.x PMid:10233437 Franco RF, Simoes BP, Tone LG, Gabellini SM, et al. (2001). The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br. J. Haematol. 115: 616-618. http://dx.doi.org/10.1046/j.1365-2141.2001.03140.x PMid:11736945 Frezza M, Tritapepe R, Pozzato G and Di Padova C (1988). Prevention of S-adenosylmethionine of estrogen-induced hepatobiliary toxicity in susceptible women. Am. J. Gastroenterol. 83: 1098-1102. PMid:3421220 Fryer AA, Zhao L, Alldersea J, Pearson WR, et al. (1993). Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A,B and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus. Biochem. J. 295: 313-315. PMid:8216235    PMCid:1134855 Hengstler JG, Arand M, Herrero ME and Oesch F (1998). Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res. 154: 47-85. http://dx.doi.org/10.1007/978-3-642-46870-4_4 Hiragi CO, Miranda-Vilela AL, Rocha DMS, Oliveira SF, et al. (2011). Superoxide dismutase, catalase, glutathione Gene polymorphisms associated with CML in Brazil peroxidase and gluthatione S-transferases M1 and T1 gene polymorphisms in three Brazilian population groups. Genet. Mol. Biol. 34: 11-18. PMid:21637536    PMCid:3085354 Hishida A, Terakura S, Emi N, Yamamoto K, et al. (2005). GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukemia in Japanese. Asian Pac. J. Cancer Prev. 6: 251-255. PMid:16235982 Hur M, Park JY, Cho HC, Lee KM, et al. (2006). Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population. Clin. Lab. Haematol. 28: 154-159. http://dx.doi.org/10.1111/j.1365-2257.2006.00769.x PMid:16706930 Ismail SI, Ababneh NA and Awidi A (2009). Methylenetetrahydrofolate reductase (MTHFR) genotype association with the risk of chronic myelogenous leukemia. Jordan Med. J. 43: 8-14. Kim DH, Xu W, Ma C, Liu X, et al. (2009). Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia. Blood 113: 2517-2525. http://dx.doi.org/10.1182/blood-2008-07-169110 PMid:19141860 Kim I, Lee KH, Kim JH, Ra EK, et al. (2007). Polymorphisms of the methylenetetrahydrofolate reductase gene and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. Ann. Hematol. 86: 41-48. http://dx.doi.org/10.1007/s00277-006-0184-3 PMid:17028897 Landi S (2000). Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat. Res. 463: 247-283. http://dx.doi.org/10.1016/S1383-5742(00)00050-8 Lourenço GJ, Ortega MM, Nascimento H, Teori MT, et al. (2005). Polymorphisms of glutathione S-transferase mu1 (GSTM1) and theta 1 (GSTT1) genes in chronic myeloid leukaemia. Eur. J. Haematol. 75: 530-531. http://dx.doi.org/10.1111/j.1600-0609.2005.00567.x PMid:16313269 Ma J, Stampfer MJ, Giovannucci E, Artigas C, et al. (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 57: 1098-1102. PMid:9067278 Maciel ME, Oliveira FK, Propst GB, Bicalho MG, et al. (2009). Population analysis of xenobiotic metabolizing genes in South Brazilian Euro and Afro-descendants. Genet. Mol. Biol. 32: 723-728. http://dx.doi.org/10.1590/S1415-47572009005000087 PMid:21637445    PMCid:3036891 Miranda-Vilela AL, Alves PC, Akimoto AK, Lordelo GS, et al. (2010). Gene polymorphisms against DNA damage induced by hydrogen peroxide in leukocytes of healthy humans through comet assay: a quasi-experimental study. Environ. Health 9: 21. http://dx.doi.org/10.1186/1476-069X-9-21 PMid:20444272    PMCid:2881052 Mitchell RJ, Carzino R and Janardhana V (1988). Associations between the two serum proteins haptoglobin and transferrin and leukaemia. Hum. Hered. 38: 144-150. http://dx.doi.org/10.1159/000153775 PMid:3397067 Mondal BC, Paria N, Majumdar S, Chandra S, et al. (2005). Glutathione S-transferase M1 and T1 null genotype frequency in chronic myeloid leukaemia. Eur. J. Cancer Prev. 14: 281-284. http://dx.doi.org/10.1097/00008469-200506000-00014 PMid:15901999 Moon HW, Kim TY, Oh BR, Min HC, et al. (2007). MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in Korea. Leuk. Res. 31: 1213-1217. http://dx.doi.org/10.1016/j.leukres.2006.10.016 PMid:17156840 Nei M (1977). F-statistics and analysis of gene diversity in subdivided populations. Ann. Hum. Genet. 41: 225-233. http://dx.doi.org/10.1111/j.1469-1809.1977.tb01918.x PMid:596830 Nevo S and Tatarsky I (1986). Serum haptoglobin types and leukemia. Hum. Genet. 73: 240-244. http://dx.doi.org/10.1007/BF00401236 PMid:3460960 Nowicki MO, Falinski R, Koptyra M, Slupianek A, et al. (2004). BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood 104: 3746-3753. http://dx.doi.org/10.1182/blood-2004-05-1941 PMid:15304390 Oliveira JB, Bidere N, Niemela JE, Zheng L, et al. (2007). NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc. Natl. Acad. Sci. U. S. A. 104: 8953-8958. http://dx.doi.org/10.1073/pnas.0702975104 PMid:17517660    PMCid:1885609 Ozkan Y, Yardim-Akaydin S, Firat H, Caliskan-Can E, et al. (2007). Usefulness of homocysteine as a cancer marker: total thiol compounds and folate levels in untreated lung cancer patients. Anticancer Res. 27: 1185-1189. PMid:17465261 Queiroz EP (2006). A Migração Intrametropolitana no Distrito Federal e Entorno: O Conseqüente Fluxo Pendular e o Uso dos Equipamentos Urbanos de Saúde e Educação. Available at [http://www.abep.nepo.unicamp.br/encontro2006/docspdf/ABEP2006_724.pdf]. Accessed May 6, 2011. Rebbeck TR (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 6: 733-743. PMid:9298582 Robien K and Ulrich CM (2003). 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am. J. Epidemiol. 157: 571-582. http://dx.doi.org/10.1093/aje/kwg024 PMid:12672676 Robien K, Ulrich CM, Bigler J, Yasui Y, et al. (2004). Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia. Clin. Cancer Res. 10: 7592-7598. http://dx.doi.org/10.1158/1078-0432.CCR-04-1057 PMid:15569990 Rover Júnior L, Höehr NF, Vellasco AP and Kubota LT (2001). Sistema antioxidante envolvendo o ciclo metabólico da glutationa associado a métodos eletroanalíticos na avaliação do estresse oxidativo. Quim. Nova 24: 112-119. Sattler M, Verma S, Shrikhande G, Byrne CH, et al. (2000). The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J. Biol. Chem. 275: 24273-24278. http://dx.doi.org/10.1074/jbc.M002094200 PMid:10833515 Serre D and Hudson TJ (2006). Resources for genetic variation studies. Annu. Rev. Genomics Hum. Genet. 7: 443-457. http://dx.doi.org/10.1146/annurev.genom.7.080505.115806 PMid:16759172 Skibola CF, Smith MT, Kane E, Roman E, et al. (1999). Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc. Natl. Acad. Sci. U. S. A. 96: 12810-12815. http://dx.doi.org/10.1073/pnas.96.22.12810 Souza CL, Barbosa CG, Neto JPM, Barreto JH, et al. (2008). Polymorphisms in the glutathione S-transferase theta and mu genes and susceptibility to myeloid leukemia in Brazilian patients. Genet. Mol. Biol. 31: 39-41. http://dx.doi.org/10.1590/S1415-47572008000100008 Suarez-Kurtz G (2004). Pharmacogenomics in admixed populations: the Brazilian pharmacogenetics/pharmacogenomics network - REFARGEN. Pharmacogenomics J. 4: 347-348. http://dx.doi.org/10.1038/sj.tpj.6500287 PMid:15549130 Ulrich CM, Kampman E, Bigler J, Schwartz SM, et al. (1999). Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? Cancer Epidemiol. Biomarkers Prev. 8: 659-668. PMid:10744125 van der Put NM, Gabreels F, Stevens EM, Smeitink JA, et al. (1998). A second common mutation in the methylenetet-rahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am. J. Hum. Genet. 62: 1044-1051. http://dx.doi.org/10.1086/301825 PMid:9545395 Yano A, Yamamoto Y, Miyaishi S and Ishizu H (1998). Haptoglobin genotyping by allele-specific polymerase chain reaction amplification. Acta Med. Okayama 52: 173-181. PMid:9781267 Yi P, Pogribny I and Jill JS (2002). Multiplex PCR for simultaneous detection of 677 C→T and 1298 A→C polymorphisms in methylenetetrahydrofolate reductase gene for population studies of cancer risk. Cancer Lett. 181: 209. http://dx.doi.org/10.1016/S0304-3835(02)00060-5
2010
A. L. Miranda-Vilela, Akimoto, A. K., Alves, P. C. Z., Ferreira, L. B., Lordelo, G. S., Melo, J. G. M., Grisolia, C. K., Oliveira, S. F., and Klautau-Guimarães, M. N., Evidence for an association between haptoglobin and MnSOD (Val9Ala) gene polymorphisms in essential hypertension based on a Brazilian case-control study, vol. 9, pp. 2166-2175, 2010.
Akyol O, Yanik M, Elyas H, Namli M, et al. (2005). Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 29: 123-131. http://dx.doi.org/10.1016/j.pnpbp.2004.10.014 PMid:15610954   Alexander RW (1995). Hypertension and the Pathogenesis of Atherosclerosis. Hypertension 25: 155-161. http://dx.doi.org/10.1161/01.HYP.25.2.155 PMid:7843763   Alves-Silva J, da Silva SM, Guimaraes PE, Ferreira AC, et al. (2000). The ancestry of Brazilian mtDNA lineages. Am. J. Hum. Genet. 67: 444-461. http://dx.doi.org/10.1086/303004 PMid:10873790 PMCid:1287189   Barreiro LB, Laval G, Quach H, Patin E, et al. (2008). Natural selection has driven population differentiation in modern humans. Nat. Genet. 40: 340-345. http://dx.doi.org/10.1038/ng.78 PMid:18246066   Bastaki M, Huen K, Manzanillo P, Chande N, et al. (2006). Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humans. Pharmacogenet. Genomics 16: 279-286. http://dx.doi.org/10.1097/01.fpc.0000199498.08725.9c PMid:16538174   Boing AC and Boing AF (2007). Hipertensão arterial sistêmica: o que nos dizem os sistemas brasileiros de cadastramentos e informações em saúde. Rev. Bras. Hipertens. 14: 84-88.   Carretero OA and Oparil S (2000). Essential hypertension. Part I: definition and etiology. Circulation 101: 329-335. http://dx.doi.org/10.1161/01.CIR.101.3.329 PMid:10645931   Carter K and Worwood M (2007). Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases. Int. J. Lab. Hematol. 29: 92-110. http://dx.doi.org/10.1111/j.1751-553X.2007.00898.x PMid:17474882   Caulfield M, Lavender P, Farrall M, Munroe P, et al. (1994). Linkage of the angiotensinogen gene to essential hypertension. N. Engl. J. Med. 330: 1629-1633. http://dx.doi.org/10.1056/NEJM199406093302301 PMid:8177268   Chen CL, Liu Q and Relling MV (1996). Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 6: 187-191. http://dx.doi.org/10.1097/00008571-199604000-00005 PMid:9156696   Choi JY, Neuhouser ML, Barnett MJ, Hong CC, et al. (2008). Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. Carcinogenesis 29: 964-970. http://dx.doi.org/10.1093/carcin/bgn056 PMid:18296681 PMCid:2902382   Cotton SC, Sharp L, Little J and Brockton N (2000). Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am. J. Epidemiol. 151: 7-32. http://dx.doi.org/10.1093/oxfordjournals.aje.a010124 PMid:10625170   Delanghe JR, Duprez DA, De Buyzere ML, Bergez BM, et al. (1995). Refractory hypertension is associated with the haptoglobin 2-2 phenotype. J. Cardiovasc. Risk 2: 131-136. http://dx.doi.org/10.1097/00043798-199504000-00008 PMid:7606649   Delanghe J, Cambier B, Langlois M, De Buyzere M, et al. (1997). Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery. Atherosclerosis 132: 215-219. http://dx.doi.org/10.1016/S0021-9150(97)00089-0   Dominiczak AF, Negrin DC, Clark JS, Brosnan MJ, et al. (2000). Genes and hypertension: from gene mapping in experimental models to vascular gene transfer strategies. Hypertension 35: 164-172. http://dx.doi.org/10.1161/01.HYP.35.1.164 PMid:10642293   Ferreira ALA and Matsubara LS (1997). Radicais livres: conceitos, doenças relacionadas, sistema de defesa e estresse oxidativo. Rev. Assoc. Med. Bras. 43: 61-68. http://dx.doi.org/10.1590/S0104-42301997000100014 PMid:9224995   Guéye PM, Glasser N, Ferard G and Lessinger JM (2006). Influence of human haptoglobin polymorphism on oxidative stress induced by free hemoglobin on red blood cells. Clin. Chem. Lab. Med. 44: 542-547. http://dx.doi.org/10.1515/CCLM.2006.095 PMid:16681422   Harrison D, Griendling KK, Landmesser U, Hornig B, et al. (2003). Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 91: 7A-11A. http://dx.doi.org/10.1016/S0002-9149(02)03144-2   Hermes-Lima M (2004). Oxygen in Biology and Biochemistry: Role of Free Radicals. In: Functional Metabolism: Regulation and Adaptation. (Storey KB, ed.). Hoboken, New Jersey, 319-368.   Li JJ and Chen JL (2005). Inflammation may be a bridge connecting hypertension and atherosclerosis. Med. Hypotheses 64: 925-929. http://dx.doi.org/10.1016/j.mehy.2004.10.016 PMid:15780486   Messerli FH, Williams B and Ritz E (2007). Essential hypertension. Lancet 370: 591-603. http://dx.doi.org/10.1016/S0140-6736(07)61299-9   Mitrunen K, Sillanpaa P, Kataja V, Eskelinen M, et al. (2001). Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis 22: 827-829. http://dx.doi.org/10.1093/carcin/22.5.827 PMid:11323405   Nakazono K, Watanabe N, Matsuno K, Sasaki J, et al. (1991). Does superoxide underlie the pathogenesis of hypertension? Proc. Natl. Acad. Sci U. S. A. 88: 10045-10048. http://dx.doi.org/10.1073/pnas.88.22.10045 PMid:1658794 PMCid:52864   Neder MM and Borges AAN (2006). Hipertensão arterial sistêmica no Brasil: o que avançamos no conhecimento de sua epidemiologia? Rev. Bras. Hipertens. 13: 126-133.   Odawara M, Matsunuma A and Yamashita K (1997). Mistyping frequency of the angiotensin-converting enzyme gene polymorphism and an improved method for its avoidance. Hum. Genet. 100: 163-166. http://dx.doi.org/10.1007/s004390050484 PMid:9254843   Olson SH, Carlson MDA, Ostrer H, Harlap S, et al. (2004). Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer. Gynecol. Oncol. 93: 615-620. http://dx.doi.org/10.1016/j.ygyno.2004.03.027 PMid:15196853   Oparil S, Zaman MA and Calhoun DA (2003). Pathogenesis of hypertension. Ann. Intern. Med. 139: 761-776. http://dx.doi.org/10.7326/0003-4819-139-9-200311040-00011 PMid:14597461   Pasha MA, Khan AP, Kumar R, Ram RB, et al. (2002). Variations in angiotensin-converting enzyme gene insertion/ deletion polymorphism in Indian populations of different ethnic origins. J. Biosci. 27: 67-70. http://dx.doi.org/10.1007/BF02703684 PMid:11927778   Passos VMA, Assis TD and Barreto SM (2006). Hipertensão arterial no Brasil: estimativa de prevalência a partir de estudos de base populacional. Epidemiol. Serv. Saúde 15: 35-45.   Prabha S, Padma T and Ramaswamy M (1987). Haptoglobin patterns in essential hypertension and associated conditions - increased risk for Hp 2-2. Hum. Hered. 37: 345-348. http://dx.doi.org/10.1159/000153732   Queiroz EP (2006). A Migração Intrametropolitana no Distrito Federal e Entorno: o Conseqüente Fluxo Pendular e o Uso dos Equipamentos Urbanos de Saúde e Educação. http://www.abep.nepo.unicamp.br/encontro2006/docspdf/ABEP2006_724.pdf. Accessed June 20, 2010.   Rola MG and Ferreira LB (2008). Polimorfismos genéticos associados à hipertensão arterial sistêmica. Univ. Cienc. Saúde 6: 57-68.   Rigat B, Hubert C, Corvol P and Soubrier F (1992). PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 20: 1433. http://dx.doi.org/10.1093/nar/20.6.1433-a PMid:1313972 PMCid:312213   Sagnella GA, Rothwell MJ, Onipinla AK, Wicks PD, et al. (1999). A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. J. Hypertens. 17: 657-664. http://dx.doi.org/10.1097/00004872-199917050-00009 PMid:10403609   Thomas GN, Young RP, Tomlinson B, Woo KS, et al. (2000). Renin-angiotensin-aldosterone system gene polymorphisms and hypertension in Hong Kong Chinese. Clin. Exp. Hypertens. 22: 87-97. http://dx.doi.org/10.1081/CEH-100100064 PMid:10685727   Ukkola O, Erkkila PH, Savolainen MJ and Kesaniemi YA (2001). Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J. Intern. Med. 249: 451-459. http://dx.doi.org/10.1046/j.1365-2796.2001.00828.x PMid:11350569   Wang Z and Hoy WE (2004). Waist circumference, body mass index, hip circumference and waist-to-hip ratio as predictors of cardiovascular disease in Aboriginal people. Eur. J. Clin. Nutr. 58: 888-893. http://dx.doi.org/10.1038/sj.ejcn.1601891 PMid:15164109   Yano A, Yamamoto Y, Miyaishi S and Ishizu H (1998). Haptoglobin genotyping by allele-specific polymerase chain reaction amplification. Acta Med. Okayama 52: 173-181. PMid:9781267   Zhao H, Liang D, Grossman HB and Wu X (2005). Glutathione peroxidase 1 gene polymorphism and risk of recurrence in patients with superficial bladder cancer. Urology 66: 769-774. http://dx.doi.org/10.1016/j.urology.2005.04.033 PMid:16230136